申请人:Aicher Thomas Daniel
公开号:US20100105659A1
公开(公告)日:2010-04-29
Provided are compounds that are useful in the treatment and/or prevention of diseases mediated by deficient levels of glucokinase activity, such as diabetes mellitus. Also provided are methods of treating or preventing diseases and disorders characterized by underactivity of glucokinase or which can be treated by activating glucokinase.
提供了一些化合物,这些化合物在治疗和/或预防由葡萄糖激酶活性不足引起的疾病中非常有用,例如糖尿病。同时提供了治疗或预防由葡萄糖激酶活性不足或可以通过激活葡萄糖激酶治疗的疾病和疾病的方法。